DarioHealth Corp.

DRIO Nasdaq SEC CIK 1533998
Follow DarioHealth Corp. Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $5.3M +6.1% vs same quarter last year
EPS, diluted $0.73 −75.3% vs same quarter last year
Operating cash flow −$5.5M +24.7% vs same quarter last year
Operating income −$8M +15.2% vs same quarter last year
Revenue by quarter
$7.6M
$6.8M
$5.4M
$5M
$5.2M
$5.6M
$5.2M
$5.3M
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income15 fiscal years
$0$10M$20M$30MFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearRevenue
FY25$22.4M
FY24$27M
FY23$20.4M
FY22$27.7M
FY21$20.5M
FY20$7.6M
FY19$7.6M
FY18$7.4M
FY17$5.2M
FY16$2.8M
FY15$823K
FY14$51K
FY13$0
FY12-
FY11-
MarginsShare of revenue
  • Gross margin
  • Operating margin
−30000%−20000%−10000%0%10000%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearGross marginOperating margin
FY2556.6%−163.9%
FY2449.1%−213.6%
FY2329.4%−276.1%
FY2234.9%−205.4%
FY2119.3%−372.9%
FY2033.2%−394.7%
FY1934.4%−234.2%
FY1823.9%−239.2%
FY1725.4%−278.9%
FY16−29.6%−396%
FY15−103.9%−935.4%
FY14−5317.6%−22270.6%
FY13--
FY12--
FY11--
Free cash flowOperating cash flow minus capital expenditure
−$60M−$40M−$20M$0FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearFree cash flow
FY25−$26.1M
FY24−$38.7M
FY23−$31M
FY22−$48.3M
FY21−$50.7M
FY20−$17.9M
FY19−$15.8M
FY18−$11.5M
FY17−$10.8M
FY16−$9.2M
FY15−$6.4M
FY14−$9.1M
FY13−$9M
FY12−$3.5M
FY11-